Retraction Note to: Angustifoline inhibits human colon cancer cell growth by inducing autophagy along with mitochondrialmediated apoptosis, suppression of cell invasion and migration and stimulating G2/M cell cycle arrest

Zheyu Ding^1,2, Qingbo Chen¹, Bin Xiong³, Yingli Cun⁴, Hongbo Wang¹, Mingyao Xu¹

¹Department of Endoscopy, Hubei Cancer Hospital, Wuhan, Hubei 430079, China;
²Colorectal Cancer Clinical Research Center of Wuhan, Colorectal Cancer Clinical Research Center of Hubei Province, Wuhan, Hubei 430079, China;
³Department of Gastrointestinal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430079, China;
⁴Department of Abdominal Surgery, Yunnan Cancer Hospital, Kunming, Yunnan 650118, China.

Retraction note to: JBUON 2019;24(1):130-135; PMID: 30941961

Following the publication of this article [1], readers drew to our attention that part of the data was unreliable: Figures of this article appeared in other articles (by totally different authors). The authors were requested to provide the raw data and were also asked for an explanation to account for these concerns, however, the Editorial Office hasn’t received any reasonable reply. Now we completed the investigation and decided to retract this article. Authors were informed of the retraction. We thank the readers for bringing this matter to our attention. We apologize for any inconvenience it may cause.

References

1. Ding Z, Chen Q, Xiong B, Cun Y, Wang H, Xu M. Angustifoline inhibits human colon cancer cell growth by inducing autophagy along with mitochondrial-mediated apoptosis, suppression of cell invasion and migration and stimulating G2/M cell cycle arrest. JBUON 2019;24:130-5.

The original article can be found online at: https://jbuon.com/archive/24-1-130.pdf

Full Text: PDF